Skip to main content
. 2020 Nov 4;12(21):21687–21705. doi: 10.18632/aging.103975

Figure 9.

Figure 9

Illustration of a hypothetical model. Dexmedetomidine inhibits traumatic brain injury-induced inflammatory response and autophagy in vivo through inactivation of the circLrp1b/miR-27a-3p/Dram2 signaling pathway.